Researchers have developed a new artificial intelligence (AI) model that can more accurately predict how proteins interact ...

OpenProtein.AI is helping biologists stay on the cutting edge of AI with a no-code platform for protein engineering.

Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

A new method developed at Baylor College of Medicine and collaborating institutions allows researchers to better understand ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Rosalind, a specialised AI model designed for life sciences. Built to assist researchers with complex biological problems, ...

For the first time, a stem cell model has produced a structure resembling an early human embryo with a yolk-sac-like structure, from a single starting stem cell population and without direct genetic ...

GPT-Rosalind steps in the earliest and most hypothesis-driven stages, where researchers juggle vast literature, specialised ...

Recently, Michael Levitt, the 2013 Nobel Laureate in Chemistry and a tenured professor at Stanford University, made a special ...